Clinical Trial - Trial jRCTs031220724
Access comprehensive clinical trial information for jRCTs031220724 through Pure Global AI's free database. This phase not specified trial is sponsored by sponsor not specified and is currently Recruiting. The study focuses on Hepatocellular carcinoma.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCTs031220724
Recruiting
Trial Details
Japan Registry Clinical Trial • jRCTs031220724
Untitled Trial
A Phase2 study to investigate the efficacy and safety of Atezolizumab and bevacizumab with live bacterial product for unresectable HCC
Study Focus
Interventional
Sponsor & Location
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Malignant neoplasm: Hepatoblastoma
Malignant neoplasm: Liver cell carcinoma
Malignant neoplasm: Other specified carcinomas of liver
Malignant neoplasm: Liver, unspecified
Malignant neoplasm: Hepatic flexure
Data Source
Japan Registry Clinical Trial
jRCTs031220724
Non-Device Trial